The U.S. Food and Drug Administration (FDA) has updated its list of chemicals that are undergoing postmarket safety assessment. The list also newly includes information about the status of the postmarket assessments and links to public information about postmarket actions that have been taken.

bioMérieux has entered an agreement with the U.S. Food and Drug Administration (FDA) to collaboratively develop tools to combat foodborne pathogens.

FDA has announced that, thanks to voluntary phase-out by industry, toxic PFAS are no longer being sold by manufacturers for use in food-contact grease-proofing agents in the U.S. FDA also said it is working towards a validated analytical method that would enable the agency to monitor the market for PFAS in food packaging.

In this episode of Food Safety Matters, we are joined by Brian Ronholm, Director of Food Policy for Consumer Reports, who lends his insight as a consumer advocate and former regulator to a discussion around food regulatory policy and food safety legislation. We dissect a variety of current events in food safety, such as toxic heavy metals in baby foods and food additives legislation, from multiple perspectives, including industry, consumer, regulatory, and consumer advocate.

The U.S. Food and Drug Administration (FDA) has issued a guidance for industry that describes how firms can voluntarily engage with FDA before marketing food from genome-edited plants.

As part of the agency’s Leafy Greens STEC Action Plan, the U.S. Food and Drug Administration (FDA) has published a report detailing the results of targeted inspections and microbiological testing of leafy greens grown in Salinas Valley, California during the region’s 2022 harvest season.

In a recent webinar organized by the Alliance for a Stronger FDA, a top policy and legislation official from the U.S. Food and Drug Administration (FDA) provided insight to the agency’s approach to regulating cannabidiol (CBD) and kratom in foods and dietary supplements.

FDA's Foreign Supplier Verification Programs (FSVP) require importers to verify that their suppliers are producing food in a way that meets domestic food safety standards. Through continuous monitoring, FDA targets high-risk products and supply chains to ensure the most impactful FSVP inspections. 

The primary role of FDA's Coordinated Outbreak Response and Evaluation (CORE) Network is to conduct outbreak surveillance, manage the response efforts, and initiate post-outbreak activities for incidents involving FDA-regulated products. This article explores the evolution, work, and perpetual improvement of the CORE Network.

The U.S. Food and Drug Administration (FDA) has released a draft guidance for industry on collecting samples for testing seafood products subject to Detention Without Physical Examination (DWPE).